The French pharmaceutical group Sanofi and Chinaccelerator, one of China’s leading start-up accelerators, is launching a three-month pilot project to help health tech series C start-ups grow in the Chinese market.
To be selected, companies should have an existing product or service focusing on one of the following areas:
1. monitoring and management of people with diabetes;
2. Recruitment and training of healthcare professionals in hospitals;
3. medical artificial intelligence (AI);
4. big data analysis in order to reduce costs and increase transparency;
5. Management of patients suffering from Parkinson, epilepsy or insomnia.
Five start-ups will be selected to join the program.
The deadline for applications is March 18th, 2018.
Sanofi and Chinaccelerator focus on AI and big data analysis
The organizers are looking for start-ups (C series) « with an existing product or service that can address one of the challenges listed below, to tackle the Chinese market »:
1. Diabetes : « Can your start-up help Healthcare professionals track and manage diabetes patients in China? Can your product/service help these doctors better educate and advise their patients? »
2. Talent Development : « Can your start-up help hospital presidents recruit, train and retain healthcare professionals? »
3. Artificial Intelligence : « Can your start-up help Doctors and medical professionals use AI as a research tool to efficiently find and review the latest scientific developments in their field? »
4. Supply Chain : « Can your start-up help Sanofi leverage Big Data to get business insights, reduce costs, and increase transparency? »
5. Central nervous system : « Can your start-up provide a patient management system for general neurologists treating patients suffering from epilepsy, Parkinson or insomnia? »
Each selected company will pitch in front of a group of senior executives from Sanofi.
The 5 winning start-ups will receive USD20,000
Winners will benefit from Sanofi’s advice and vast network
The five winners will roll out a three-month pilot project. They will enjoy various benefits, including:
- USD$ 20,000 (€16,100) for the development of the pilot project;
- the unique opportunity to collaborate with Chinaccelerator, China’s #1 internet accelerator, and Sanofi, a world leading pharmaceutical companies;
- access to Sanofi’s vast healthcare network to distribute their product or service;
- the possibility of increasing the number of customers by leveraging the corporate resources;
- keeping all the developments their company makes during the program.
To apply, interested start-ups have to fill in the online form available on www.corpinnovation.com.